05:38 PM EDT, 08/12/2024 (MT Newswires) -- B Lynne Parshall, Director, on August 12, 2024, sold 5,000 shares in Cytokinetics ( CYTK ) for $276,000. Following the Form 4 filing with the SEC, Parshall has control over a total of 20,600 shares of the company, with 20,600 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1061983/000112760224022026/xslF345X03/form4.xml